Company Profile
AnaptysBio, Inc. Stock Price, News & Analysis
- Ticker:
- ANAB
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, AnaptysBio is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
59.43 USD (-0.93%)
Close
Last updated: June 23, 2026 at 00:00
1.73B USD
Market cap
Why the stock is moving
ANAB is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
AnaptysBio is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, AnaptysBio is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
AnaptysBio follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, AnaptysBio sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update
Source: AnaptysBio, Inc.
- 02
Anaptys Appoints Chris Murphy as Chief Financial Officer and Owen Hughes to Board of Directors
Source: AnaptysBio, Inc.
- 03
Anaptys to Present at the 44th Annual J.P. Morgan Healthcare Conference
Source: AnaptysBio, Inc.
- 04
- 05
Anaptys Announces Participation at Upcoming Investor Conferences
Source: AnaptysBio, Inc.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of AnaptysBio, Inc. (ANAB)?
AnaptysBio, Inc. (ANAB) most recently closed at 59.43 USD, a -0.93% move versus the previous session.
What is the market cap of AnaptysBio, Inc. (ANAB)?
AnaptysBio, Inc. currently has a market capitalization of 1.73B USD on BioPharmSignal.
What does AnaptysBio, Inc. do?
AnaptysBio is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is ANAB stock listed?
AnaptysBio, Inc. (ANAB) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, AnaptysBio is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is AnaptysBio?
AnaptysBio is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is AnaptysBio, Inc. targeting with AnaptysBio?
AnaptysBio is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.